This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Valeant, Pershing Square file lawsuit against Allergan

( August 25, 2014, 16:31 GMT | Official Statement) -- MLex Summary: Valeant Pharmaceuticals International and Pershing Square on Friday filed a lawsuit against Allergan and its board, alleging that the Allergan bylaws for calling a special meeting are invalid and that the companies' directors breached their fiduciary duties with respect to the special meeting request. Valeant and Pershing requested that a judge force Allergan to hold a special meeting within a reasonable period of time.Excerpt....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login